You are here

  • Home
  • Archive
  • Volume 9, Issue 10
  • Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

Article metrics

Article menu

Download PDFPDF

Case report
Treatment of recurrent mucosal melanoma of the oral cavity with topical imiquimod and pembrolizumab achieves complete histopathologic remission

 

Online download statistics by month:

Online download statistics by month: October 2021 to March 2026

AbstractFullPdf
Oct 202118018026
Nov 202135935980
Dec 202118318330
Jan 202215615732
Feb 202218618726
Mar 2022828338
Apr 202211812847
May 20229810128
Jun 202212212314
Jul 202212312525
Aug 202212812914
Sep 202211511518
Oct 202214114328
Nov 202212312323
Dec 202212112120
Jan 202397975
Feb 202311311418
Mar 202311811810
Apr 202312812819
May 202311711710
Jun 202312112112
Jul 202311811818
Aug 2023991015
Sep 20231301318
Oct 202312112110
Nov 202313212811
Dec 20231141148
Jan 202448495
Feb 2024575617
Mar 202412212267
Apr 2024939329
May 2024858615
Jun 2024676716
Jul 2024777818
Aug 202470676
Sep 202441417
Oct 2024565622
Nov 202481839
Dec 202464669
Jan 2025818111
Feb 20251161137
Mar 2025747218
Apr 2025727226
May 2025494916
Jun 2025343410
Jul 2025210
Aug 2025400
Nov 2025100
Dec 2025300
Jan 2026100
Feb 2026100
Mar 2026300
Total49454951891